It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Blood-based biomarkers of Alzheimer disease (AD) may facilitate testing of historically under-represented groups. The Study of Race to Understand Alzheimer Biomarkers (SORTOUT-AB) is a multi-center longitudinal study to compare AD biomarkers in participants who identify their race as either Black or white. Plasma samples from 324 Black and 1,547 white participants underwent analysis with C2N Diagnostics’ PrecivityAD test for Aβ42 and Aβ40. Compared to white individuals, Black individuals had higher average plasma Aβ42/40 levels at baseline, consistent with a lower average level of amyloid pathology. Interestingly, this difference resulted from lower average levels of plasma Aβ40 in Black participants. Despite the differences, Black and white individuals had similar longitudinal rates of change in Aβ42/40, consistent with a similar rate of amyloid accumulation. Our results agree with multiple recent studies demonstrating a lower prevalence of amyloid pathology in Black individuals, and additionally suggest that amyloid accumulates consistently across both groups.
Plasma samples from 324 Black and 1,547 white participants underwent analysis with C2N Diagnostics’ Precivity AD test for Aβ42 and Aβ40. Compared to white individuals, Black individuals had higher average plasma Aβ42/40 levels at baseline, consistent with a lower average level of amyloid pathology.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Washington University, Division of Biostatistics, St. Louis, USA (GRID:grid.34477.33) (ISNI:0000 0001 2298 6657); Washington University School of Medicine, Department of Neurology, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002)
2 Washington University School of Medicine, Division of Public Health Sciences, Department of Surgery, St. Louis, USA (GRID:grid.4367.6); Washington University School of Medicine, Siteman Cancer Center Biostatistics and Qualitative Research Shared Resource, St. Louis, USA (GRID:grid.4367.6)
3 University of Pennsylvania, Perelman School of Medicine, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972)
4 University of Pennsylvania, Perelman School of Medicine, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972); University of Pennsylvania, Department of Pathology and Laboratory Medicine, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972)
5 University of Alabama at Birmingham, Alzheimer’s Disease Center, Department of Neurology, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000 0001 0634 4187)
6 Washington University School of Medicine, Department of Neurology, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002)
7 Washington University School of Medicine, Department of Neurology, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002); Washington University, Mallinckrodt Institute of Radiology, St. Louis, USA (GRID:grid.34477.33) (ISNI:0000 0001 2298 6657)
8 Washington University, Division of Biostatistics, St. Louis, USA (GRID:grid.34477.33) (ISNI:0000 0001 2298 6657)
9 University of Alabama at Birmingham, Alzheimer’s Disease Center, Department of Neurology, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000 0001 0634 4187); University of Alabama at Birmingham, Department of Psychology, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000 0001 0634 4187)